The downregulation of BNIP3 under hypoxic conditions may provide an advantage towards the increased survival of the tumor cells, whereas patients with low BNIP3 levels are expected to exhibit lower survival rate [26]. The gene discussed is BNIP3; the disease is neoplasm.